predictive response
Recently Published Documents


TOTAL DOCUMENTS

42
(FIVE YEARS 12)

H-INDEX

8
(FIVE YEARS 1)

2021 ◽  
Vol Volume 16 ◽  
pp. 1617-1629
Author(s):  
Leo Delaire ◽  
Aymeric Courtay ◽  
Mathieu Fauvernier ◽  
Joannès Humblot ◽  
Marc Bonnefoy

Diagnostics ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1417
Author(s):  
Cristina Ferrari ◽  
Giulia Santo ◽  
Rossella Ruta ◽  
Valentina Lavelli ◽  
Dino Rubini ◽  
...  

Differentiated thyroid cancer (DTC) represents the most common thyroid cancer histotype. Generally, it exhibits a good prognosis after conventional treatments; nevertheless, about 20% of patients can develop a local recurrence and/or distant metastasis. In one-third of advanced DTC, the metastatic lesions lose the ability to take up iodine and become radioactive iodine-refractory (RAI-R) DTC. In this set of patients, the possibility to perform localized treatments should always be taken into consideration before the initiation of systemic therapy. In the last decade, some multi-tyrosine kinase inhibitor (MKI) drugs were approved for advanced DTC, impacting on patient’s survival rate, but at the same time, these therapies have been associated with several adverse events. In this clinical context, the role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) in the early treatment response to these innovative therapies was investigated, in order to assess the potentiality of this diagnostic tool in the early recognition of non-responders, avoiding unnecessary therapy. Herein, we aimed to present a critical overview about the reliability of [18F]FDG PET/CT in the early predictive response to MKIs in advanced differentiated thyroid cancer.


2020 ◽  
Vol 65 (2) ◽  
pp. 424-428
Author(s):  
Srinidi Mohan ◽  
Seema Patel ◽  
David Barlow ◽  
Augusto Cardenas Rojas

2020 ◽  
Vol 27 (17) ◽  
pp. 2814-2825
Author(s):  
Francesco Fiorica ◽  
Maria Colella ◽  
Rosaria Taibi ◽  
Andrea Bonetti ◽  
Jacopo Giuliani ◽  
...  

: Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. : Here we try to summarize the main clinical and biological factors impacting clinical prognostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Kazushi Tsutsui ◽  
Masahiro Shinya ◽  
Kazutoshi Kudo

AbstractFor modern humans, chase-and-escape behaviors are fundamental skills in many sports. A critical factor related to the success or failure of chase-and-escape is the visuomotor delay. Recent studies on sensorimotor decision making have shown that humans can incorporate their own visuomotor delay into their decisions. However, the relationship between the decision of an attacker and the visuomotor delay of a defender is still unknown. Here, we conducted a one-on-one chase-and-escape task for humans and investigated the characteristics of the direction changes of the attacker and the responses of the defender. Our results showed that the direction change of the attacker has two characteristics: uniformity of spatial distribution and bimodality of temporal distribution. In addition, we showed that the response of the defender did not depend on the position but it was delayed to the direction change of the attacker with a short interval. These results suggest that the characteristics of direction change of an attacker increased unpredictability, and it could be useful for preventing the predictive response of the defender and to receive the benefit of an extra response delay of tens of milliseconds, respectively.


2019 ◽  
Vol 152 (10) ◽  
pp. 377-383
Author(s):  
Eduard Brunet ◽  
Leticia Hernández ◽  
Mireia Miquel ◽  
Jordi Sánchez-Delgado ◽  
Blai Dalmau ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document